ACTRN12606000404527已完成3 期
A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program
The Woolcock Institute of Medical Research0 个研究点目标入组 60 人开始时间: 2006年9月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- Male
入选标准
- •No significant uncontrolled medical problems.
排除标准
- •Severe OSA ((minimum oxygen saturation < 65% or RDI > 80) requiring immediate treatment due to severity or increased associated risk (eg Transport worker), Use of drugs that alter androgen action, Contraindications to testosterone therapy, Desire for paternity within the next 12 months, Participation in sports that ban testosterone and require drug monitoring, Psychiatric disorders or drug abuse unless well controlled,Chronic medical conditions likely to interfere with or influence study treatment or safety unless well controlled.
研究者
相似试验
招募中
3 期
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
已完成
4 期
Testosterone for gender dysphoria in transgender meDepressionTransgender healthGender dysphoriaSuicideMetabolic and Endocrine - Other endocrine disordersMental Health - DepressionMental Health - SuicideACTRN12621000716864niversity of Melbourne64
进行中（未招募）
1 期
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
已完成
不适用
A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapseservous System Diseases: Multiple sclerosis (MS)Nervous System DiseasesISRCTN95588376Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)164
已完成
不适用
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30